Open AccessIntracerebral bleeding after Janus-kinase inhibitor baricitinib for COVID-19
Author(s) -
Josef Finsterer,
Fúlvio A. Scorza
Publication year - 2021
Publication title -
brain hemorrhages
Language(s) - Uncategorized
Resource type - Journals
ISSN - 2589-238X
DOI - 10.1016/j.hest.2021.06.005
Subject(s) - medicine , intracerebral hemorrhage , blood pressure , stroke (engine) , cardiology , hyperlipidemia , endocrinology , diabetes mellitus , mechanical engineering , subarachnoid hemorrhage , engineering
Intracerebral hemorrhage/bleeding (ICH) after an infection with SARS-CoV-2 (COVID-19) treated with the Janus-kinase inhibitor baricitinib has not been reported.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom